MicroRNAs Used to Diagnose and Classify Renal-Cell Carcinoma: Presented at ASCP
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




MicroRNAs Used to Diagnose and Classify Renal-Cell Carcinoma: Presented at ASCP

By Maggie Schwarz

BALTIMORE, Md -- October 20, 2008 -- The expression profile of unique microribonucleic acids (microRNAs) may be useful in the diagnosis and prognosis of papillary renal-cell carcinoma, clear-cell renal-cell carcinoma, and chromophobe renal-cell carcinoma, according to research presented here at the American Society for Clinical Pathology (ASCP) 2008 Annual Meeting.

"This is the first study to find a role of microRNA in these 3 types of renal-cell carcinoma," announced Gary Tozbikian, MD, University of Pennsylvania, Philadelphia, Pennsylvania, in a presentation on October 17.

MicroRNAs modulate gene expression and are differentially expressed between a tumour and corresponding normal kidney tissue.

Dr. Tozbikian and colleagues identified a distinct subset of microRNAs in the 3 categories of tumours. In papillary renal-cell carcinoma, 4 microRNAs were up-regulated and 2 down-regulated. In clear-cell renal-cell carcinoma, 7 microRNAs were up-regulated and 2 down-regulated. In chromophobe renal-cell carcinoma, 20 microRNAs were up-regulated and 3 down-regulated. Nine microRNAs were differentially expressed between chromophobe and papillary renal-cell carcinomas.

Reverse-transcriptase polymerase chain reaction confirmed the results, using 6 probes for microRNA.

Formalin-fixed paraffin-embedded tissue can be used to study microRNA profiles, Dr. Tozbikian explained.

He added that the diagnostic utility of microRNAs merits study in the classification of renal-cell carcinoma.

[Presentation title: MicroRNA Profiles of Papillary, Chromophobe, and Conventional Renal Cell Carcinomas.]

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities